Allarity Therapeutics completed its Phase 3-ready manufacturing for stenoparib ahead of schedule, eliminating further API cash outlays. This milestone supports its continued development towards FDA approval.
Read Full Story →
Allarity Therapeutics completed its Phase 3-ready manufacturing for stenoparib ahead of schedule, eliminating further API cash outlays. This milestone supports its continued development towards FDA approval.
The Elliðaárstöð power station in Reykjavík has been transformed by Terta into a vibrant cultural hub, showcasing the potential of adaptive reuse in architecture.
DP World secures a €25 million green loan from EBRD to electrify its Constanța terminal, emphasizing sustainable infrastructure development in the logistics sector.
Suncrete maintains its fiscal 2026 revenue outlook of $420 million to $480 million, despite weather challenges, driven by strong demand and strategic acquisitions in the Sunbelt region.
Taiwanese innovations showcased at Automate 2026 are advancing smart manufacturing, impacting AECM and government contracting sectors.
Ominimo's $1.6B valuation and Series B funding led by EBRD set the stage for U.S. expansion in 2027, signaling potential shifts in the insurance landscape for AECM professionals.
VISOID raises $2.5 million to enhance its AI-powered architectural visualization platform, impacting rendering processes globally.
Lauren Gibbs' leadership of Gibbs Construction highlights the challenges and opportunities of generational transitions in family-owned construction businesses, offering valuable insights for AECM professionals.
Tersis Technologies appoints recycling expert Paul Vanderpool as Strategic Advisor to boost its plastics recycling capabilities, offering opportunities and insights for AECM professionals.
